Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 10/31/06
End: -
Due: -
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus | NCT00800007 | Anza Therapeutics, Inc. | user2@example.com | None | 2008-11-30 | 2009-02-28 | 2010-02-28 | - | - | 2025-07-14 |
| Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment | NCT00585845 | Anza Therapeutics, Inc. | user2@example.com | None | 2007-12-31 | 2009-02-28 | 2010-02-28 | - | - | 2025-07-14 |
| Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases | NCT00327652 | Anza Therapeutics, Inc. | user2@example.com | None | 2006-10-31 | - | - | - | - | 2025-07-14 |